What is Heartflow, Inc. Common Stock's market cap?

Heartflow, Inc. Common Stock (HTFL) has a market capitalization of $2.4B and trades on NASDAQ.

What is Heartflow, Inc. Common Stock's revenue and profitability?

Heartflow, Inc. Common Stock generated $191.4M in trailing twelve-month revenue with a net loss of $111.8M, representing a net margin of -58.4%. Gross margin stands at 78.1%, with free cash flow of -$76.8M. These figures are based on the Q1 2026 filing.

Who are Heartflow, Inc. Common Stock's competitors?

Heartflow, Inc. Common Stock's key competitors include GE HealthCare, Heartbeam, Inc. Common Stock, Boston Scientific Corp., and others. These companies compete in similar markets and product categories.

Who does Heartflow, Inc. Common Stock partner with?

Heartflow, Inc. Common Stock's notable partners include American Heart Association, American College of Cardiology.

Where is Heartflow, Inc. Common Stock headquartered?

Heartflow, Inc. Common Stock is headquartered in United States of America. It has been publicly traded since 2025.

HTF

Heartflow, Inc. Common Stock

HTFL

Heartflow is a medical technology company providing an AI-powered software platform for the non-invasive diagnosis and management of coronary artery disease (CAD).

Market cap

$2.39B-16.6%

Revenue$191.4M+40.6%

Net income-$111.8M-3.7%

Free cash flow-$76.8M-31.8%

EPS (diluted)-$8.07+55.1%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q1 2026 report

May 14, 2026

Revenue$52.6MBeat by $2.9M EPS-$0.16Beat by $0.02

Read the full report

Next report

Aug 13, 2026 (in a month)

Revenue estimate$56.6M

EPS estimate-$0.13

Financials

Q1 2026

Income statement

See full

Revenue$52.6M+41.3%

Gross profit$42.2M+50.9%

Operating income-$29.5M-68.6%

Net income-$27.4M+15.4%

EPS (diluted)-$0.32+93.9%

Balance sheet

See full

Cash & equivalents$24.4M-78.7%

Total debt$26.3M—

Total equity$285.7M+132%

Total assets$344.0M—

Cash flow

See full

Operating cash flow-$30.1M-129%

CapEx$1.9M+71.6%

Free cash flow-$32.0M-124%

Valuation & ratios

Valuation

See full

Market cap$2.39B-16.6%

Enterprise value$2.39B—

P/S12.5×—

Profitability

See full

Gross margin78.1%+2.4pp

Operating margin-39.7%-4.8pp

Net margin-58.4%-12.1pp

FCF margin-40.1%-2.4pp

Returns & leverage

See full

Debt / equity0.1×—

Current ratio5.6×—

Competitors

By market cap

Medtronic$105.46B-6.1%

Boston Scientific$66.9B-56.5%

GE HealthCare Technologies$29.4B-13.8%

ITG

Integer Holdings$3.1B-23.5%

HTF

Heartflow, Inc. Common Stock$2.4B—

Heartbeam, Inc.$35.5M-19.2%

Heart Test Laboratories, Inc.$8.8M+115%

bioAffinity Technologies, Inc.$4.9M-41.4%

By revenue growth

HTF

Heartflow, Inc. Common Stock+40.6%

Boston Scientific+17.4%

Medtronic+8.4%

ITG

Integer Holdings+6.3%

GE HealthCare Technologies+6.0%

By net margin

Boston Scientific17.26%+5.7pp

Medtronic13.2%-0.7pp

GE HealthCare Technologies9.1%-1.9pp

ITG

Integer Holdings7.64%+3.2pp

HTF

Heartflow, Inc. Common Stock-58.42%+20.8pp

Profile

Heartflow is a medical technology company providing an AI-powered software platform for the non-invasive diagnosis and management of coronary artery disease (CAD). The company leverages deep learning and computational fluid dynamics to create personalized 3D models of a patient's heart from standard CCTA scans, delivering actionable insights on blood flow and plaque composition. Its core value proposition is reducing the need for invasive procedures while improving the accuracy of CAD detection compared to traditional stress-based testing.

Competitive position

Heartflow is a leading provider of AI-powered CAD testing, with its flagship FFRCT product representing the vast majority of its revenue and holding significant clinical validation through major trials.

GeographiesUnited States

Customer segmentsHealthcare Providers, Diagnostic Imaging Centers

Business modelSaaS, Usage-based, Cloud-based software

SuppliersCCTA scanner manufacturers, Cloud infrastructure providers, Medical imaging data

CustomersInterventional cardiologists, Diagnostic radiologists, Hospital systems, Health insurance payers

CountryUnited States of America

Listed2025

CEOJohn Farquhar

SectorHealthcare

IndustryMedical - Healthcare Information Services

Websiteheartflow.com

FilingsSEC EDGAR

Ask your AI about Heartflow, Inc. Common Stock.

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Heartflow, Inc. Common Stock's market cap?: Heartflow, Inc. Common Stock (HTFL) has a market capitalization of $2.4B and trades on NASDAQ.
What is Heartflow, Inc. Common Stock's revenue and profitability?: Heartflow, Inc. Common Stock generated $191.4M in trailing twelve-month revenue with a net loss of $111.8M, representing a net margin of -58.4%. Gross margin stands at 78.1%, with free cash flow of -$76.8M. These figures are based on the Q1 2026 filing.
Who are Heartflow, Inc. Common Stock's competitors?: Heartflow, Inc. Common Stock's key competitors include GE HealthCare, Heartbeam, Inc. Common Stock, Boston Scientific Corp., and others. These companies compete in similar markets and product categories.
Who does Heartflow, Inc. Common Stock partner with?: Heartflow, Inc. Common Stock's notable partners include American Heart Association, American College of Cardiology.
Where is Heartflow, Inc. Common Stock headquartered?: Heartflow, Inc. Common Stock is headquartered in United States of America. It has been publicly traded since 2025.